Beam Therapeutics Inc.
BEAM
16.99
USD+0.32
(+1.92%)Day's range
16.33
17.52
52 wk Range
13.525
35.25
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 24,000 | 51,844,000 | 60,920,000 | 377,709,000 | 63,518,000 | |
| Gross Profit | -103,155,000 | 35,403,000 | 38,343,000 | -59,672,000 | 41,593,000 | |
| Operating Income | -132,760,000 | -392,465,000 | -338,479,000 | -176,485,000 | -415,568,000 | |
| Net Income | -256,424,000 | -341,360,000 | -263,588,000 | -132,527,000 | -376,742,000 | |
| Total Assets | 451,677,000 | 1,474,453,000 | 1,341,714,000 | 1,459,714,000 | 1,103,824,000 | |
| Total Current Liabilities | 102,337,000 | 213,435,000 | 223,595,000 | 205,565,000 | 182,066,000 | |
| Total Equity | 245,561,000 | 826,738,000 | 733,474,000 | 981,329,000 | 733,545,000 | |
| Free Cash Flow | -112,098,000 | -113,079,000 | -26,424,000 | -182,927,000 | -356,192,000 | |
| Cash from Operations | -95,741,000 | -66,268,000 | 22,527,000 | -149,195,000 | -347,246,000 | |
| Cash from Investing | -100,123,000 | -294,144,000 | -461,336,000 | 71,840,000 | 185,007,000 | |
| Cash from Financing | 322,322,000 | 756,141,000 | 111,590,000 | 276,448,000 | 7,736,000 | |
| Net Change in Cash | 126,458,000 | 395,729,000 | -327,219,000 | 199,093,000 | -154,503,000 |